These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 16922259)
21. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer. Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017 [TBL] [Abstract][Full Text] [Related]
25. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response. Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420 [TBL] [Abstract][Full Text] [Related]
26. New radiotherapy approaches in locally advanced non-small cell lung cancer. Christodoulou M; Bayman N; McCloskey P; Rowbottom C; Faivre-Finn C Eur J Cancer; 2014 Feb; 50(3):525-34. PubMed ID: 24333095 [TBL] [Abstract][Full Text] [Related]
27. Adjuvant therapy for resected extrahepatic cholangiocarcinoma: a review of the literature and future directions. Anderson C; Kim R Cancer Treat Rev; 2009 Jun; 35(4):322-7. PubMed ID: 19147294 [TBL] [Abstract][Full Text] [Related]
28. Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies. Ben-Josef E; Normolle D; Ensminger WD; Walker S; Tatro D; Ten Haken RK; Knol J; Dawson LA; Pan C; Lawrence TS J Clin Oncol; 2005 Dec; 23(34):8739-47. PubMed ID: 16314634 [TBL] [Abstract][Full Text] [Related]
29. High-dose-rate intracavitary brachytherapy combined with external beam radiotherapy for stage IIIb adenocarcinoma of the uterine cervix in Japan: a multi-institutional study of Japanese Society of Therapeutic Radiology and Oncology 2006-2007 (study of JASTRO 2006-2007). Niibe Y; Kenjo M; Onishi H; Ogawa Y; Kazumoto T; Ogino I; Tsujino K; Harima Y; Takahashi T; Anbai A; Tsuchida E; Toita T; Takemoto M; Yamashita H; Hayakawa K Jpn J Clin Oncol; 2010 Aug; 40(8):795-9. PubMed ID: 20444747 [TBL] [Abstract][Full Text] [Related]
30. Proximal biliary tumors. Brown KM; Geller DA Surg Clin North Am; 2014 Apr; 94(2):311-23. PubMed ID: 24679423 [TBL] [Abstract][Full Text] [Related]
31. Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime. Martinez AA; Demanes DJ; Galalae R; Vargas C; Bertermann H; Rodriguez R; Gustafson G; Altieri G; Gonzalez J Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1322-31. PubMed ID: 16029788 [TBL] [Abstract][Full Text] [Related]
32. Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base. Karakoyun-Celik O; Norris CM; Tishler R; Mahadevan A; Clark JR; Goldberg S; Devlin P; Busse PM Head Neck; 2005 May; 27(5):353-61. PubMed ID: 15726587 [TBL] [Abstract][Full Text] [Related]
33. Liver transplantation for perihilar cholangiocarcinoma after aggressive neoadjuvant therapy: a new paradigm for liver and biliary malignancies? Heimbach JK; Gores GJ; Nagorney DM; Rosen CB Surgery; 2006 Sep; 140(3):331-4. PubMed ID: 16934588 [No Abstract] [Full Text] [Related]
34. Postoperative adjuvant transcatheter arterial chemoembolisation improves survival of intrahepatic cholangiocarcinoma patients with poor prognostic factors: results of a large monocentric series. Wu ZF; Zhang HB; Yang N; Zhao WC; Fu Y; Yang GS Eur J Surg Oncol; 2012 Jul; 38(7):602-10. PubMed ID: 22417704 [TBL] [Abstract][Full Text] [Related]
35. Can increasing the dose of radiation by HDR brachytherapy boost following pre operative chemoradiotherapy for advanced rectal cancer improve surgical outcomes? Sun Myint A; Mukhopadhyay T; Ramani VS; Perkins K; Snee AJ; Jelley F; Wong H; Lee CD Colorectal Dis; 2010 Aug; 12 Suppl 2():30-6. PubMed ID: 20618365 [TBL] [Abstract][Full Text] [Related]
36. Hepatic portal cholangiocarcinoma: a clinical analysis of 70 cases. Zhang HY; Kong YL; Zhang HY; He XJ; Zhang H; Liu CL; Zhao G; Xiao M; Zhang XD; Feng ZQ Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):418-21. PubMed ID: 18693179 [TBL] [Abstract][Full Text] [Related]
37. Diagnosis and management of cholangiocarcinomas: a comprehensive review. Yalcin S Hepatogastroenterology; 2004; 51(55):43-50. PubMed ID: 15011829 [TBL] [Abstract][Full Text] [Related]
38. Main bile duct carcinoma management. Our experience on 38 cases. Cavallaro A; Cavallaro V; Di Vita M; Cappellani A Ann Ital Chir; 2009; 80(2):107-11. PubMed ID: 19681291 [TBL] [Abstract][Full Text] [Related]
39. Long term results of a prospective dose escalation phase-II trial: interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer. Lettmaier S; Lotter M; Kreppner S; Strnad A; Fietkau R; Strnad V Radiother Oncol; 2012 Aug; 104(2):181-6. PubMed ID: 22853851 [TBL] [Abstract][Full Text] [Related]